Latest News for HNSBF
Hansa Biopharma AB (publ) (OTCMKTS:HNSBF - Get Free Report) saw a large drop in short interest during the month of March. As of March 31st, there was short interest totaling 11,135 shares, a drop of 15.6% from the March 15th total of 13,194 shares. Based on an average daily volume of 0 shares, the days-to-cover
Hansa Biopharma AB (publ) (HNSBF) Q4 2025 Earnings Call Transcript
LUND, Sweden, Jan. 22, 2026 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced that the company has been awarded the prestigious 2025 SwedenBIO Award. The award was presented at the SwedenBIO Summit in Stockholm on 21 January, where Hansa was selected as the winner among the many nominated companies.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for HNSBF.
Senate Trading
No Senate trades found for HNSBF.
U.S. House Trading
No House trades found for HNSBF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.